Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling.
Shixing ZhuJiayuan ZhangZhihua LvPeijuan ZhuCharles OoMingming YuSherwin K B SyPublished in: Clinical pharmacokinetics (2022)
The physiologically based pharmacokinetic modeling supports pediatric dosing regimens of meropenem/colistin/sulbactam in a co-administration setting against infections in the blood, lung, skin, and heart tissues due to A. baumannii.